Rejuran
Rejuran is a clinician-administered skin treatment containing polynucleotides (PN), derived from salmon DNA. It is used in clinical settings by registered health practitioners to support skin health as part of a personalised treatment plan.
Polynucleotides (PN): Long-chain molecules that, when administered by a trained practitioner, are intended to interact with skin tissue to support natural cellular activity.
Skin response support: The treatment is used by clinicians as part of a comprehensive care plan to support skin hydration, elasticity, and overall appearance.
Personalised approach: Treatment technique, injection depth, and areas treated are customised by your clinician based on your skin assessment.
Conditions Commonly Assessed
During consultation, we may discuss Rejuran for concerns such as:
Fine lines and early signs of ageing
Mild loss of skin elasticity or firmness
Skin hydration support
Subtle textural irregularities
Suitability depends on skin type, medical history, and individual goals. Not all clients are suitable candidates.
Ingredients in NCTF® Boost
Treatments are performed in a clinical setting by trained, registered practitioners
The clinician will prepare the skin and administer Rejuran via microinjection
Local anaesthesia or numbing agents may be applied for comfort if appropriate
Session duration depends on the areas being treated and your personalised plan
Mild redness, swelling, or tenderness may be observed immediately after treatment
Your Consultation
Before treatment, we will:
Review your medical history and skin concerns
Assess the skin to determine suitability
Explain how Rejuran is administered and what to expect
Discuss potential risks, benefits, alternatives, and aftercare
Ensure you have all the information needed to make an informed decision
-
Temporary reactions may include redness, minor swelling, or tenderness
Aftercare guidance is provided to support recovery, which may include gentle cleansing, moisturising, and sun protection
Recovery varies between individuals
-
Rejuran treatments are clinician-directed and performed in a safe clinical environment
Effects vary between individuals; no specific outcomes are guaranteed
Follow-up sessions may be recommended as part of a personalised care plan
-
Rejuran is used as part of a regulated health service provided by registered practitioners
This page provides factual, educational information and does not make unverified therapeutic claims
Suitability and outcomes vary; all treatments are clinician-directed
Content aligns with AHPRA advertising guidelines and TGA requirements for therapeutic goods
-
As with any injectable skin treatment, there are potential risks and side effects that clients should be aware of.
Common, Temporary Reactions
Redness, swelling, or mild tenderness at the treatment site, usually resolving within a few hours to a couple of days.
Minor bruising or pinpoint bleeding at injection sites, which generally subsides within several days.
Less Common or Rare Risks
Hypersensitivity reactions (allergic or sensitivity responses) are rare but may occur.
Infection can occur if aftercare instructions are not followed or the skin is exposed to contaminants.
Localised irritation or small lumps at injection sites, which are typically temporary and resolve as the skin recovers.
Risk Minimisation
All treatments are clinician-directed and preceded by a thorough consultation and skin assessment.
Following post-treatment care instructions carefully can significantly reduce the risk of complications.
Patients should inform their clinician of any medical conditions, medications, allergies, or previous reactions to injectable treatments prior to treatment.
Any unusual or persistent reactions should be promptly reported to your practitioner.
Important: Rejuran is used to support natural skin processes under professional supervision. Individual responses vary, and no specific results are guaranteed.